Confocal microscopy may help identify biomarkers for chemotherapy-induced neuropathy

Confocal microscopy may help identify biomarkers for chemotherapy-induced neuropathy

A University of Arizona Comprehensive Cancer Center researcher received a $2.4 million National Cancer Institute grant to develop a noninvasive, confocal microscope to examine nerve endings of cancer patients with chemotherapy-induced peripheral neuropathy in the hopes of identifying potential biomarkers for the disease.

University of Arizona researchers develop new microscope to detect chemo nerve damage early

University of Arizona researchers are building a powerful new microscope to catch chemo-related nerve damage before it becomes permanent.

$2.4 million grant will fund development of optical imaging technology for chemotherapy-induced peripheral neuropathy

TUCSON, Arizona, May 22, 2025 — A University of Arizona Comprehensive Cancer Center researcher received a $2.4 million National Cancer Institute grant to develop a noninvasive, confocal microscope to examine nerve endings of cancer patients with chemotherapy-induced peripheral neuropathy in the hopes of identifying potential biomarkers for the disease. Peripheral neuropathy is a common side effect of certain chemotherapy […] The post $2.4 millio…